Portfolio Lab

Cabot Corp

  • Stock
  • Ticker CBT
  • ISIN US1270551013
  • NYSE

Materials · Chemicals · USA

$70.48 −3.23%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Cabot Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CBTGlobal equities (VT)

$10,000 grew to $17,180. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −67.2% in 03/2020, measured from the peak in 01/2018. It took 39 months to get back to the old peak.

1-year return
+23.0%
5-year return p.a.
+5.7%
10-year return p.a.
+5.6%
Volatility p.a.
33.4%
Largest decline
−67.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue9559369238998499049821,009
Gross profit235241244220211210184204
Operating income15516216713712912998121
EBITDA192200206177170178148172
Net income93941014373686.066
Earnings per share1.671.691.860.801.371.270.121.25
Balance sheet
Total assets3,6423,7843,8373,8153,7573,8973,9754,028
Liabilities2,1272,1942,1542,1102,0282,2102,2412,257
Equity1,3661,4271,5411,5501,5751,5681,6051,635
Cash183213239258230252250254
Long-term debt1,0891,0901,1058568548638281,180
Cash flow
Operating cash flow124732492191267775143
Capital expenditure-77-72-61-64-69-45-38-55
Free cash flow471.018815557323788

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +28.4%, weakest 2018 at −28.7%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
20 Nov 2026$1.25
4 Aug 2026$0.12
6 May 2026$1.27
4 Feb 2026$1.37
24 Nov 2025$0.80
5 Aug 2025$1.86
7 May 2025$1.69
6 Feb 2025$1.67
20 Nov 2024$2.42
6 Aug 2024$1.94
9 May 2024$1.49
8 Feb 2024$0.88

Key metrics

Metrics of 21 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.3bn
Market cap in trading currency
$3.62bn
Enterprise value
$4.59bn
P/E
17.5
P/S
0.97
P/B
2.22
EV/Sales
1.23
EV/EBITDA
6.9
Earnings yield
5.7%
FCF yield
5.9%

Results (last four quarters)

Revenue
$3.74bn
Gross profit
$809m
EBITDA
$668m
Net income
$213m
Earnings per share
$4.02
Revenue per share
$72.85
Revenue growth
+12.2%
Earnings growth
+53.5%

Profitability

Gross margin
21.6%
Operating margin
12.7%
Net margin
5.7%
Return on equity
13.4%
Return on assets
5.3%

Balance sheet and cash flow

Cash
$254m
Cash per share
$4.94
Financial debt
$1.22bn
Debt/equity %
75
Current ratio
2.16
Book value per share
$31.81
Operating cash flow
$421m
Free cash flow
$214m

Dividend

Dividend yield
2.62%
Dividend (12 months)
$1.85
Yield (12 months)
2.62%
Payout ratio
46%
Ex-dividend date
28 Aug 2026

Shares and trading

Shares outstanding
51.4m
Volume
475,855
Avg. volume 3 months
394,504
Relative volume
1.2

Price and technicals

Price
$70.48
1 day
−3.2%
52-week high
$93.40
52-week low
$58.71
Distance to 52-week high
−24.5%
Distance to 52-week low
+20.0%
Distance to 50-day line
−6.0%
Distance to 200-day line
−11.4%
RSI (14)
41
Volatility 1M
37.7%

Performance

1 week
−2.0%
1 month
−5.2%
3 months
−16.0%
6 months
−15.5%
YTD
+6.3%
1 year
+17.9%

Dates

Fiscal year end
30 Sep 2026
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CBT performed since 11/2016?

$10,000 grew to $17,180 by 20 Nov 2026, which is +5.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CBT?

Volatility was 33.4% per year, measured on monthly returns. The largest decline from a peak was −67.2%, with the low in 03/2020.

How does CBT compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CBT returned +5.6% at 33.4%. The correlation of monthly returns was 0.60; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Cabot Corp (CBT): Return and risk | Portfolio Lab